rfhg_72847.1

Basic information about the TSS

---

TSS ID: rfhg_72847.1 Species: human Chr: chr5		Start: 139322621 End: 139322782 Strand: +
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000512040.1:0 GeneID: 9782 HGNC/MGI_ID: HGNC:6912 UniProt_ID: Nearer transcript ids and distances:

Gene_name: matrin 3 Gene_symbol: MATR3 Gene_synonyms: KIAA0723 MGC9105 VCPDM Gene_source: HGNC:6912

TATA-Box annotation

---

Distance to TSS:	-19131
Nearest PromoterID:	NR_109830
Entrez ID:	51247
Nearest Unigene:	Hs.396644
Nearest Refseq:	NM_016480
Nearest Ensembl:	ENSG00000120727
Gene Name:	matrin 3
Gene Alias:	PAIP-2|PAIP2A
Gene Type:	protein-coding
CpG%:	0.012422
GC%:	0.425926
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MATR3 p2@MATR3 p3@MATR3 p4@MATR3 p8@MATR3
Sample		p1@MATR3	p2@MATR3	p3@MATR3	p4@MATR3	p8@MATR3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	103.05	37.01	20.45	21.82	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	92.26	27.52	24.28	17.60	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	95.68	38.00	25.85	21.80	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	82.12	34.51	23.08	18.30	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	76.94	36.67	20.92	16.65	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	77.33	33.53	25.78	22.09	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	86.28	47.50	24.84	18.74	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	90.35	29.79	21.56	12.84	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	73.73	30.78	20.09	15.17	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	146.65	62.60	46.95	27.82	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	135.82	51.74	36.79	23.04	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	127.25	45.94	37.00	23.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	53.35	11.12	7.09	8.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	55.48	13.08	7.22	6.92	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	55.55	12.73	7.03	6.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	58.85	14.33	6.04	3.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	50.45	12.23	6.99	4.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	42.60	13.92	8.86	7.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	35.72	11.73	6.40	5.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	45.13	13.99	7.37	6.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	59.07	14.97	8.69	6.82	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	66.81	15.71	5.18	11.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	53.25	13.18	6.98	6.20	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	63.09	14.56	8.01	8.74	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	53.66	13.42	8.26	9.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	41.46	13.61	6.96	7.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	56.04	12.09	8.24	6.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	68.37	16.74	8.25	9.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	49.10	10.82	8.40	7.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	66.78	14.48	11.58	9.59	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	58.83	12.35	6.49	6.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	52.95	11.72	9.38	7.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	50.65	10.97	7.17	6.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	70.43	16.99	8.25	7.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	60.58	17.20	10.47	6.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	62.47	15.14	10.73	9.77	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	63.97	12.88	8.18	8.38	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	60.45	12.90	8.46	7.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	64.55	12.96	9.72	9.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	52.81	14.64	6.24	7.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	55.52	11.29	6.12	8.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	60.61	17.57	7.32	7.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	66.43	15.82	5.69	7.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	63.46	13.64	9.44	10.14	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	61.44	18.07	7.43	11.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	57.93	17.22	9.77	5.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	60.70	16.07	7.44	5.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	56.63	17.58	7.75	5.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	54.82	11.97	8.62	8.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	61.47	8.49	8.69	7.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	50.21	15.58	7.38	6.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	56.04	13.34	5.56	6.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	405.77	97.95	41.98	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	62.46	14.90	6.03	4.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	60.64	12.59	7.95	3.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	114.10	39.43	8.39	10.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	70.26	22.04	4.59	6.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	83.30	11.67	9.08	8.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	61.02	11.88	8.67	5.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	85.81	20.75	11.32	10.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	61.34	19.04	10.58	8.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	55.52	6.73	15.14	3.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	60.51	12.74	8.76	6.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	69.99	10.87	9.17	5.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	76.03	13.00	14.30	8.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	70.64	13.13	9.94	10.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	598.07	48.49	32.33	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	473.85	86.87	31.59	31.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	51.19	8.78	7.31	7.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	60.50	12.40	7.44	6.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	56.76	10.79	8.91	7.04	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	58.62	13.25	7.29	6.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	68.36	9.59	6.50	5.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	49.22	9.17	7.03	7.95	0.31
Adipocyte - breast, donor1	11376-118A8	60.50	28.35	20.75	6.49	0.16
Adipocyte - breast, donor2	11327-117E4	41.87	13.96	8.98	5.78	0.00
Adipocyte - omental, donor1	11473-119C6	80.92	31.30	19.72	7.25	0.00
Adipocyte - omental, donor2	11474-119C7	44.85	11.21	18.69	3.74	0.00
Adipocyte - omental, donor3	11475-119C8	56.27	13.06	11.05	4.02	0.00
Adipocyte - perirenal, donor1	11476-119C9	44.02	11.48	24.88	7.66	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	21.99	2.20	2.20	3.30	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	40.65	8.13	4.06	4.52	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	30.24	5.91	6.26	3.13	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	102.09	19.95	14.08	18.58	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	37.32	9.27	7.72	4.63	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	43.77	11.71	4.18	3.62	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	46.44	9.99	6.47	2.94	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	85.18	22.76	11.42	14.16	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	53.58	14.85	4.20	4.52	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	51.72	11.20	6.93	6.40	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	38.95	11.13	7.23	3.90	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	41.17	13.31	10.40	4.99	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	47.72	12.56	7.03	6.53	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	35.34	11.45	4.91	4.91	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	31.67	12.18	3.04	5.18	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	14.36	2.65	4.86	2.21	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	7.89	0.36	2.87	2.51	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	34.54	3.06	4.50	1.80	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	0.00	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.66	3.29	2.47	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	81.13	31.24	15.10	8.47	0.00
Anulus Pulposus Cell, donor2	11463-119B5	48.49	17.39	7.84	4.16	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	45.83	19.77	7.19	4.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	45.15	14.33	5.64	6.51	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	38.52	8.56	8.56	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	38.56	12.85	5.98	5.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	44.26	16.44	7.59	5.06	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.68	7.26	7.92	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	35.41	12.35	5.20	4.22	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	33.01	18.93	9.22	3.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	39.20	17.82	5.94	3.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	45.95	19.59	4.52	5.27	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	36.28	15.96	5.08	7.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	10.03	6.27	3.76	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	53.21	30.15	12.52	7.08	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	32.76	20.47	2.73	4.09	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	65.14	20.96	13.57	10.71	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	36.97	13.93	4.29	4.29	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	48.18	14.74	8.50	7.18	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	30.20	15.50	9.36	5.08	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	43.90	15.61	2.93	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	48.76	17.42	6.63	7.30	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	19.21	6.00	7.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	24.78	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	35.34	15.09	9.09	4.29	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	49.03	13.11	5.83	3.88	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	54.26	15.56	8.35	5.69	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	33.92	9.69	4.85	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	48.45	19.95	4.56	3.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	39.76	17.10	7.70	6.41	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.10	13.94	7.74	3.61	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	44.57	13.61	6.57	3.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	32.15	17.04	7.07	8.68	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	39.24	14.27	6.42	2.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	33.93	14.04	2.92	3.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	43.66	14.45	7.23	6.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	15.44	13.07	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	46.79	16.27	2.54	5.09	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	47.63	16.05	8.15	7.13	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	25.41	12.07	8.90	3.81	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	38.41	12.95	6.47	6.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	49.32	17.15	7.83	6.99	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.68	12.18	4.64	2.61	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	41.57	16.06	5.67	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	40.01	17.97	8.98	7.80	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	44.01	9.27	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	59.15	21.13	6.34	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	35.38	18.23	7.93	6.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	27.68	19.85	9.63	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	45.93	13.12	5.83	4.37	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	48.96	17.01	11.26	6.67	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	15.30	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	56.95	20.08	16.27	9.92	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	42.94	21.88	9.08	9.70	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	36.41	14.08	8.87	4.59	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	50.67	23.90	6.21	5.26	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	38.36	14.63	8.87	10.42	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	27.46	10.68	4.58	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	34.34	13.29	3.32	3.88	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	38.13	19.59	6.62	5.83	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	27.26	17.81	6.54	3.27	0.00
Astrocyte - cerebellum, donor1	11500-119F6	48.88	8.35	8.72	6.51	0.00
Astrocyte - cerebellum, donor2	11580-120F5	18.49	3.42	3.59	3.59	0.00
Astrocyte - cerebellum, donor3	11661-122F5	12.38	2.10	1.89	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	192.77	43.22	30.68	21.96	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	110.17	22.49	23.62	20.87	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	121.86	21.48	19.09	16.56	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	160.22	35.32	25.69	30.05	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	161.99	44.22	30.07	28.69	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	146.57	45.63	25.83	29.70	1.82
Basophils, donor1	12241-129G9	43.41	22.75	14.38	10.72	0.00
Basophils, donor2	12242-129H1	202.05	61.70	47.99	45.10	0.00
Basophils, donor3	12243-129H2	113.63	25.14	21.61	31.60	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	7.11	1.29	3.02	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	6.40	0.00	2.29	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	46.45	5.65	8.16	4.39	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	12.27	2.08	5.20	1.66	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	17.73	2.07	3.45	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	44.63	9.90	8.82	5.22	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	154.07	39.37	29.68	20.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	172.35	33.54	43.32	33.31	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	205.62	74.19	31.98	32.94	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	62.05	51.71	31.03	0.00
CD14+ Monocytes, donor1	11224-116B9	81.15	37.76	22.54	23.11	0.56
CD14+ Monocytes, donor2	11305-117B9	85.19	44.17	27.65	24.68	0.00
CD14+ Monocytes, donor3	11381-118B4	90.45	33.37	27.66	24.59	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	100.76	31.98	15.57	7.08	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	135.33	35.63	21.23	18.20	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	115.39	34.19	16.11	12.16	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	78.35	26.74	16.33	14.02	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	67.89	26.55	12.97	9.96	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	73.67	27.48	17.53	9.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	42.02	24.27	9.54	7.87	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	51.61	25.95	12.14	9.38	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	86.03	26.28	17.11	11.90	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	35.44	17.82	11.36	7.24	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	47.36	19.23	11.57	8.55	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	103.37	31.99	17.63	14.36	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	43.08	20.84	12.64	8.90	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	69.70	33.27	18.48	10.56	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	85.42	35.50	17.75	13.31	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	56.52	21.57	13.09	9.97	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	79.22	25.14	14.77	11.17	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	101.39	40.60	17.70	13.95	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	53.99	19.68	8.47	12.13	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	77.14	37.78	16.51	10.41	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	60.23	24.01	12.66	11.78	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	46.00	17.22	12.10	4.84	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	69.44	21.11	13.61	10.64	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	69.86	30.72	17.25	8.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	49.97	22.05	7.16	9.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	54.60	16.20	11.98	9.16	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	64.93	21.50	12.72	8.77	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	49.35	17.44	14.47	8.54	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	47.20	17.10	10.41	9.29	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	102.17	38.58	23.71	13.36	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	43.82	20.06	12.28	8.60	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	79.74	33.38	14.14	11.36	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	85.37	37.35	21.34	9.98	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	119.88	30.73	17.66	11.77	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	100.25	31.18	15.94	7.85	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	99.86	25.99	13.00	10.61	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	111.65	29.43	19.78	12.61	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	114.57	24.28	20.78	13.27	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	133.11	36.79	16.72	13.82	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	67.88	21.43	12.76	6.89	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	100.12	27.88	12.52	8.78	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	121.48	30.11	15.58	9.47	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	221.52	26.42	24.39	14.23	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	189.16	27.12	33.22	16.95	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	211.26	30.03	41.42	15.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	214.81	32.52	42.64	25.05	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	282.51	28.41	43.96	26.27	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	205.67	35.80	34.39	23.16	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	204.72	28.24	29.02	27.45	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	229.38	27.68	26.37	14.50	1.32
CD19+ B Cells, donor1	11544-120B5	230.13	56.71	57.53	29.59	0.82
CD19+ B Cells, donor2	11624-122B4	217.63	47.88	50.05	50.05	0.00
CD19+ B Cells, donor3	11705-123B4	205.46	47.96	44.42	52.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	296.17	47.68	21.01	16.97	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	204.54	34.36	20.77	12.38	0.00
CD34+ Progenitors, donor1	11545-120B6	154.62	44.18	23.09	19.08	0.00
CD34+ Progenitors, donor2	11625-122B5	208.43	80.90	36.52	42.14	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	214.56	59.37	19.54	33.44	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	178.81	61.11	27.73	23.68	0.00
CD4+ T Cells, donor1	11225-116C1	388.12	112.12	94.62	82.48	0.00
CD4+ T Cells, donor2	11306-117C1	202.69	71.03	71.03	61.24	0.00
CD4+ T Cells, donor3	11382-118B5	232.10	65.88	46.66	62.52	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	177.90	21.44	16.34	13.78	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	211.12	19.32	24.03	18.87	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	165.86	32.48	23.57	14.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	299.15	64.00	43.14	39.82	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	287.25	73.04	42.84	35.82	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	224.14	72.52	39.55	42.85	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	161.57	42.20	19.37	10.69	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	110.32	20.00	14.40	11.18	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	107.20	18.54	16.60	13.38	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	264.05	49.31	31.83	26.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	267.98	43.67	30.05	30.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	260.47	66.44	44.00	35.64	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	155.59	46.80	23.61	9.28	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	123.62	21.61	16.21	15.37	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	92.55	20.05	17.04	7.02	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	283.63	70.43	51.94	34.26	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	333.90	89.50	53.06	33.23	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	229.53	60.97	46.62	25.11	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	176.16	39.87	19.10	14.09	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	193.66	30.11	19.50	16.46	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	197.75	38.88	19.96	19.12	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	208.81	57.13	25.79	25.79	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	213.59	65.85	30.76	26.86	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	356.93	87.60	44.45	39.22	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	289.50	61.86	40.08	32.17	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	243.72	56.31	35.08	21.23	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	202.39	39.08	34.90	15.35	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	366.10	76.71	41.54	41.26	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	461.58	81.96	55.70	38.28	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	220.22	81.62	40.04	20.02	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	293.30	58.37	33.30	30.44	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	304.70	59.55	23.54	26.31	0.00
CD8+ T Cells, donor1	11226-116C2	320.52	97.24	56.97	60.24	0.33
CD8+ T Cells, donor2	11307-117C2	163.69	61.95	50.31	54.44	0.00
CD8+ T Cells, donor3	11383-118B6	255.27	74.74	62.87	71.96	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	54.60	16.52	10.78	7.11	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	47.69	18.93	11.98	3.83	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	46.51	16.69	11.76	4.10	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	71.75	22.82	15.01	9.31	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	50.64	15.12	10.56	6.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	55.03	19.10	12.96	6.14	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	60.40	18.25	16.30	6.95	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	62.12	13.69	10.79	8.95	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	53.24	17.59	12.66	6.80	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	67.62	15.70	12.38	7.85	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	52.87	20.04	10.17	5.81	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	71.67	18.65	10.92	7.46	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	49.90	10.07	13.57	4.38	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	43.27	13.66	10.93	10.93	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	13.43	10.44	8.95	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	59.79	15.13	10.44	5.04	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	56.11	17.26	9.21	7.19	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	43.37	17.21	10.37	5.66	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	70.04	17.11	13.63	9.51	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	59.05	21.22	11.38	9.84	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	61.23	16.99	9.62	8.01	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	74.20	20.27	11.09	11.86	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	65.42	18.13	8.67	5.12	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	50.68	12.86	12.86	6.81	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	119.64	23.29	23.29	16.86	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	102.12	24.48	25.88	22.38	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	152.27	26.05	20.04	16.03	2.00
Cardiac Myocyte, donor1	11525-119I4	62.14	7.31	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	49.41	10.87	9.88	6.92	0.00
Cardiac Myocyte, donor3	11686-122I3	87.34	16.00	15.47	14.52	0.00
Chondrocyte - de diff, donor1	11261-116G1	135.55	23.23	19.41	12.13	0.00
Chondrocyte - de diff, donor2	11338-117F6	51.53	15.28	6.04	2.84	0.00
Chondrocyte - de diff, donor3	11410-118E6	58.37	16.50	7.17	6.37	0.00
Chondrocyte - re diff, donor2	11339-117F7	101.16	24.17	12.53	3.58	0.00
Chondrocyte - re diff, donor3	11411-118E7	34.78	8.49	6.07	2.43	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	155.84	44.87	28.00	19.39	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	68.62	20.95	14.75	10.26	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	76.64	25.93	15.49	14.87	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	101.88	30.54	25.58	16.41	1.74
Corneal Epithelial Cells, donor1	11526-119I5	5.49	1.76	2.42	1.10	0.00
Corneal Epithelial Cells, donor2	11606-120I4	3.41	1.14	1.14	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.50	1.28	4.09	2.05	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	76.60	40.61	11.89	7.26	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	58.35	32.17	11.35	8.52	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	58.66	34.51	6.90	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	36.82	23.22	8.75	6.59	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	257.60	45.78	38.61	39.29	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	233.07	49.62	42.44	40.48	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	299.56	59.04	48.39	41.62	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	32.35	6.00	5.00	4.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	25.23	4.69	8.80	4.69	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	22.62	3.39	7.35	3.39	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	16.12	7.08	7.86	3.54	0.00
Endothelial Cells - Artery, donor1	11264-116G4	23.27	4.07	4.94	4.07	0.00
Endothelial Cells - Artery, donor2	11341-117F9	51.53	11.76	10.82	11.06	0.00
Endothelial Cells - Artery, donor3	11413-118E9	32.43	3.68	7.19	5.79	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	83.56	20.17	19.95	9.75	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	98.28	24.95	20.08	14.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	110.51	27.63	23.68	18.89	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	39.52	7.13	5.65	3.86	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	29.16	7.81	5.21	4.17	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	19.57	2.41	2.55	4.40	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	94.83	19.21	15.20	10.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	18.87	4.72	2.62	4.72	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	149.72	29.20	26.84	21.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	43.02	12.38	9.78	10.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	42.13	12.33	14.78	10.75	0.00
Endothelial Cells - Vein, donor1	11267-116G7	25.03	4.55	6.83	13.65	0.00
Endothelial Cells - Vein, donor2	11344-117G3	27.94	4.89	11.18	4.19	0.00
Endothelial Cells - Vein, donor3	11416-118F3	30.62	6.91	7.85	6.75	0.16
Eosinophils, donor1	12244-129H3	137.22	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	143.57	56.11	84.16	46.21	0.00
Eosinophils, donor3	12246-129H5	96.30	53.50	64.20	17.83	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.86	1.22	3.42	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	16.27	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	59.94	15.19	15.19	5.75	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	16.20	10.29	4.27	2.74	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.52	11.59	4.55	2.82	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	77.26	27.17	13.95	10.07	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	196.25	55.41	30.84	41.90	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	41.45	15.71	5.70	6.12	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	228.45	28.72	17.65	20.03	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	69.10	12.62	11.29	9.97	0.00
Fibroblast - Cardiac, donor1	11268-116G8	54.44	12.25	8.62	8.62	0.00
Fibroblast - Cardiac, donor2	11345-117G4	37.14	7.58	3.79	5.31	0.00
Fibroblast - Cardiac, donor3	11417-118F4	29.02	12.78	6.15	4.73	0.00
Fibroblast - Cardiac, donor4	11452-119A3	99.42	29.40	17.28	16.97	0.00
Fibroblast - Cardiac, donor5	11456-119A7	81.35	15.10	10.41	10.66	0.00
Fibroblast - Cardiac, donor6	11460-119B2	75.95	12.89	14.55	11.22	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	39.39	7.50	6.30	4.42	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	48.32	18.12	10.35	10.35	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	79.10	30.76	8.79	11.72	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	29.98	3.46	3.00	2.77	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	100.58	26.63	11.70	8.31	0.00
Fibroblast - Dermal, donor1	11269-116G9	33.10	12.91	8.69	4.93	0.00
Fibroblast - Dermal, donor2	11346-117G5	27.83	5.66	6.13	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	42.31	13.06	6.77	5.68	0.00
Fibroblast - Dermal, donor4	11450-119A1	107.62	15.37	17.75	13.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	120.20	18.49	18.84	12.39	0.00
Fibroblast - Dermal, donor6	11458-119A9	141.31	18.52	21.28	18.19	0.16
Fibroblast - Gingival, donor1	11237-116D4	79.96	19.99	12.49	7.50	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	63.14	21.75	8.65	6.03	0.00
Fibroblast - Gingival, donor2	11318-117D4	87.90	12.65	16.87	12.39	0.00
Fibroblast - Gingival, donor3	11394-118C8	64.97	15.86	7.83	7.64	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	73.76	16.62	9.35	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	39.29	12.16	6.52	5.99	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	84.50	14.81	15.75	9.51	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	62.34	13.93	14.88	7.84	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.41	3.18	3.18	2.47	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	62.45	18.72	17.26	9.07	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	63.27	19.63	15.68	5.59	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	93.13	11.63	15.47	12.61	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	56.93	17.76	7.78	8.22	0.00
Fibroblast - Lung, donor1	11270-116H1	13.59	1.36	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	89.53	31.34	8.95	11.94	0.00
Fibroblast - Lung, donor3	11419-118F6	51.91	7.39	6.54	9.07	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	22.49	4.17	4.17	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	1.40	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.56	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	28.42	5.68	5.68	2.44	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	130.74	19.79	17.46	11.64	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	103.14	17.29	19.26	16.69	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	111.69	23.26	18.05	18.97	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	61.44	12.21	8.78	5.34	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	43.74	10.53	6.21	6.48	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.07	10.67	4.29	4.87	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	86.99	15.81	14.92	11.72	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	17.88	1.22	3.25	1.22	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	2.67	0.67	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	56.93	13.84	7.91	7.51	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	305.21	26.00	31.95	28.18	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	78.51	23.62	12.43	7.46	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	79.03	25.03	14.78	8.87	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	218.42	22.86	27.38	21.66	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	128.35	30.66	16.73	11.33	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	278.89	32.90	29.61	27.84	0.00
Fibroblast - skin normal, donor1	11553-120C5	80.89	26.25	15.10	6.23	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	318.41	34.69	42.71	48.72	0.00
Fibroblast - skin normal, donor2	11561-120D4	118.34	26.32	18.49	10.75	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	375.08	45.34	48.96	44.13	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	89.06	27.92	14.08	8.20	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	180.01	35.90	18.46	14.53	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	204.28	24.96	22.66	18.39	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	120.48	20.67	15.98	11.61	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	73.54	11.98	13.33	6.58	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	40.93	13.96	4.55	3.61	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	598.31	221.60	177.28	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	68.85	18.30	8.72	8.72	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	57.90	12.83	11.44	9.01	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	75.99	13.27	12.49	14.05	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	63.62	15.84	10.73	7.41	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	118.66	37.51	36.75	16.08	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	118.04	56.15	38.92	14.04	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	220.51	93.57	55.06	64.75	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	199.92	34.75	45.22	37.23	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	172.84	44.52	26.71	23.06	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	169.80	59.04	36.06	35.66	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	205.65	45.47	47.05	36.48	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	155.57	44.36	26.42	26.42	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	176.01	89.33	56.16	44.22	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	180.47	80.70	21.62	27.70	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	130.53	54.31	25.49	22.78	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	107.45	56.41	28.74	22.56	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	104.44	26.14	13.38	13.01	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	114.06	28.38	14.26	15.64	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	78.68	31.92	13.42	12.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	88.08	18.71	20.54	13.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	97.41	22.42	15.70	13.58	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	61.42	17.27	15.08	12.68	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	87.76	29.25	18.02	17.73	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	120.33	31.00	13.67	15.10	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	82.22	27.03	17.87	15.86	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	99.00	25.00	18.95	14.52	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	156.24	43.09	17.98	18.83	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	170.25	41.50	30.33	19.06	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	176.90	49.95	26.12	17.17	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	153.53	52.60	21.69	19.30	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	144.29	35.41	15.71	13.83	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	173.88	48.67	27.70	18.72	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	133.33	53.50	21.44	13.27	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	109.14	24.76	16.71	11.55	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	133.74	32.51	15.91	17.99	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	89.39	24.51	15.01	18.34	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	78.91	25.79	15.65	11.02	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	128.03	33.95	13.16	15.87	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	102.93	26.26	15.40	15.89	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	68.95	31.75	13.79	13.79	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	94.75	27.76	13.27	12.32	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	81.94	21.04	14.24	9.65	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	96.70	24.94	10.03	13.99	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	109.66	27.08	13.59	11.50	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	69.82	22.61	9.88	8.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	81.64	24.13	16.27	14.03	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	72.68	26.20	8.70	9.35	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	62.84	28.08	13.64	10.43	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	66.40	22.34	8.87	13.01	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	68.78	21.89	8.55	10.10	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	66.68	20.33	10.03	8.13	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	73.00	19.91	11.06	14.56	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	79.61	20.18	14.26	10.09	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	60.50	26.78	10.91	9.92	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	65.82	15.83	9.63	9.23	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	60.33	15.13	8.47	6.66	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	114.37	38.89	20.33	15.50	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	320.09	148.50	56.53	47.18	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	161.63	74.88	23.27	20.95	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	219.11	109.66	29.87	29.87	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	141.44	59.46	36.61	26.60	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	161.06	70.64	38.99	21.76	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	166.50	87.63	35.05	25.37	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	123.74	81.67	29.70	22.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	163.62	71.95	35.97	23.60	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	149.22	48.13	33.69	27.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	133.89	45.21	22.60	27.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	146.47	60.54	30.27	22.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	183.25	64.65	34.59	23.06	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	209.93	39.99	26.66	13.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	161.64	48.66	25.73	21.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	159.17	48.05	26.15	24.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	148.47	41.94	35.23	31.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	166.03	50.89	28.94	15.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	158.28	38.38	25.47	20.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	194.20	52.20	12.53	22.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	163.22	33.79	22.91	17.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	108.03	19.24	15.98	12.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	191.44	54.21	32.19	32.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	217.87	45.56	28.99	25.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	199.98	52.70	36.36	30.15	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	163.32	31.61	15.81	26.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	151.46	40.36	22.30	16.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	162.99	33.57	23.80	22.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	126.41	28.76	19.40	16.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	155.26	30.05	19.65	18.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	154.40	34.23	20.20	21.57	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	99.39	9.94	9.94	24.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	109.00	21.23	24.06	17.46	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	117.68	18.71	15.69	15.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	138.36	31.54	22.38	18.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	157.94	28.32	24.33	15.95	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	146.53	20.23	23.68	13.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	125.13	15.35	20.07	22.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	122.52	32.09	16.92	14.59	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	102.70	16.24	19.31	14.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	103.42	30.52	20.34	16.95	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	84.16	21.49	13.73	12.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	151.88	35.42	26.20	16.50	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	30.82	7.99	1.14	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	42.00	7.90	5.41	4.99	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	28.11	5.62	4.50	5.62	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	40.91	13.64	7.61	5.39	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	34.25	18.38	7.94	4.18	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	85.64	24.14	16.13	12.30	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	99.26	26.84	24.31	14.18	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	94.19	30.26	19.57	12.51	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	84.93	27.44	15.52	12.57	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	86.61	25.36	19.56	11.39	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	84.18	27.56	21.96	11.63	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	74.10	22.04	15.69	12.95	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	76.00	25.90	17.15	11.67	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	77.85	19.22	15.70	9.93	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	18.47	2.24	3.92	3.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	0.43	2.16	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	63.45	7.93	10.58	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.87	3.88	3.53	2.82	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	0.00	1.45	2.18	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	67.14	16.96	11.19	13.99	0.00
Hepatocyte, donor1	11523-119I2	48.42	23.00	2.42	2.42	0.00
Hepatocyte, donor2	11603-120I1	61.41	9.70	5.39	7.54	0.00
Hepatocyte, donor3	11684-122I1	70.56	9.20	11.04	11.04	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	161.21	39.81	19.58	13.71	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	128.11	33.38	30.06	16.25	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	72.86	20.99	13.45	14.82	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	165.56	3.18	12.74	9.55	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	6.68	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	80.29	5.54	26.30	12.46	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	55.06	2.50	7.51	5.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	130.55	0.00	35.60	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	128.15	5.13	15.38	17.94	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	0.00	13.71	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	123.45	3.25	22.74	19.49	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	116.71	8.34	18.34	13.34	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	90.76	3.63	7.26	7.26	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	121.76	5.29	30.44	26.47	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	88.69	4.43	19.96	14.41	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	167.63	5.24	10.48	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	142.98	4.41	15.75	18.27	8.82
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	126.82	0.00	24.75	23.20	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	0.00	0.00	0.00	43.90
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	181.54	3.88	24.55	21.32	7.75
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	181.92	8.05	24.15	32.20	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	0.00	11.95	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	218.39	8.96	30.97	22.82	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	156.17	3.36	19.73	18.05	3.78
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	202.53	7.23	24.11	27.33	8.04
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	81.25	5.54	11.08	10.16	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	15.08	0.00	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	82.13	2.83	10.86	14.16	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	124.26	6.35	20.86	13.60	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	14.74	0.00	29.48	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	148.50	4.30	30.13	12.91	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	167.70	3.81	16.52	24.14	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	0.00	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	155.59	5.10	22.96	8.93	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	114.83	9.11	20.05	12.76	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	121.39	8.57	14.28	16.42	5.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	136.05	13.27	16.59	29.86	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	97.85	4.94	11.73	8.64	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	201.94	8.78	35.12	35.12	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	160.30	3.14	22.00	18.86	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	193.32	6.26	13.91	20.17	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	57.54	8.85	4.43	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	9.73	6.48	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	64.52	1.74	8.72	4.36	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	0.00	9.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	66.21	0.00	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	54.41	3.20	1.07	8.53	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	95.60	6.93	5.54	9.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	125.38	5.70	28.50	11.40	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	61.67	6.44	12.89	3.68	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	9.08	6.05	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	45.47	0.00	3.17	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	44.80	15.50	12.24	5.71	0.00
Keratinocyte - epidermal, donor2	11349-117G8	21.08	3.51	2.34	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	69.00	9.28	8.24	7.38	0.00
Keratinocyte - oral, donor1	11251-116E9	88.66	29.29	17.48	13.62	0.00
Keratocytes, donor1	11527-119I6	17.54	3.09	2.41	1.38	0.00
Keratocytes, donor2	11607-120I5	8.20	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	64.42	4.35	10.08	9.48	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	6.59	6.59	6.59	0.00
Lens Epithelial Cells, donor1	11529-119I8	48.54	14.02	11.87	7.55	0.00
Lens Epithelial Cells, donor2	11609-120I7	133.79	42.44	15.45	16.95	0.00
Lens Epithelial Cells, donor3	11690-122I7	86.98	30.98	16.15	16.35	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	48.50	11.50	8.54	8.18	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	18.14	6.42	5.86	3.07	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	53.52	17.79	10.39	8.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.05	11.29	2.69	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	15.76	4.41	2.52	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	17.90	2.91	2.91	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.52	13.54	11.90	5.34	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.12	2.02	2.02	2.53	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	17.73	6.62	3.38	4.64	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	33.62	10.28	8.31	4.75	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	30.25	9.69	6.40	6.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	8.33	2.22	2.78	0.93	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	34.15	9.06	4.88	3.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	17.65	5.72	4.77	2.86	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	14.42	2.61	3.57	2.47	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	34.18	10.16	7.39	6.78	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.53	2.18	2.18	2.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	15.37	3.66	2.93	2.20	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.91	12.84	5.59	3.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.66	3.22	3.51	2.34	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.20	2.99	2.24	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	24.25	12.12	9.70	7.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	24.78	7.00	7.27	4.31	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.71	4.69	4.39	4.09	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.29	9.33	3.63	3.11	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	37.27	9.21	10.26	6.07	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	17.74	4.51	4.21	3.01	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	39.90	8.94	8.94	5.50	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	28.03	5.46	5.08	3.76	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	11.88	2.44	2.76	2.12	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	32.95	10.18	5.81	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	3.31	4.96	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.03	3.35	2.11	2.23	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	54.05	18.88	9.26	9.26	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	28.41	5.93	5.68	6.18	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.96	2.34	3.71	2.06	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	36.02	12.22	10.29	8.36	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	35.00	12.17	9.13	4.56	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	33.73	11.06	7.56	6.44	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	33.07	9.24	10.67	6.04	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	1.94	3.88	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.87	2.33	3.11	2.02	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.56	6.80	5.01	3.58	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.07	2.61	3.27	4.25	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.59	1.18	2.35	1.65	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	38.86	7.67	9.41	9.78	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.73	1.28	5.12	3.33	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.60	3.28	3.58	2.98	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	45.32	13.60	6.80	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	42.96	11.51	9.21	8.44	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	30.43	8.16	8.91	3.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	25.81	5.92	7.19	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	27.43	8.44	5.63	7.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.02	4.67	8.41	4.67	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.55	8.24	8.76	3.61	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	23.79	4.76	8.33	10.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	38.23	10.63	13.12	7.46	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	49.73	22.98	16.00	8.72	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	62.12	21.16	10.80	12.15	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	41.05	14.50	14.90	8.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	36.46	10.78	14.38	6.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	53.99	16.58	14.47	13.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	39.98	13.99	19.32	5.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	48.39	12.73	15.79	8.66	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	57.90	22.68	12.27	17.88	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	69.91	19.08	13.42	14.36	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	36.81	7.98	12.27	6.14	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	40.77	17.94	13.05	8.15	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	54.56	17.91	14.16	16.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	59.98	18.78	19.34	7.57	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	34.00	14.42	8.24	6.18	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	65.61	20.03	15.39	11.32	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	44.24	18.23	17.64	10.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	46.47	12.72	16.60	13.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	38.88	10.96	12.73	7.42	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	44.25	9.22	14.75	8.48	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	43.75	9.21	9.21	9.21	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	36.84	11.90	11.13	7.68	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.34	6.79	13.02	6.79	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	38.56	5.74	10.67	9.85	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	30.73	7.68	8.13	6.33	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.78	15.08	11.49	8.62	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	53.03	14.19	12.70	16.43	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	28.24	8.92	10.78	5.95	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	40.92	13.78	12.92	6.89	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	46.24	12.84	12.84	3.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	42.31	10.33	9.66	10.99	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	35.60	6.64	12.67	5.43	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	34.84	5.69	8.53	4.27	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	38.84	6.53	8.59	9.28	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.84	8.05	6.44	5.90	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	28.95	8.08	10.10	10.77	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	37.04	10.00	9.63	8.15	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	9.30	10.47	5.81	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	26.44	7.40	7.40	6.35	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	32.41	9.20	6.80	10.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	27.62	8.00	12.36	8.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	45.99	7.67	9.96	11.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	32.56	9.87	7.89	6.91	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	12.23	6.59	4.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	27.66	8.05	9.55	11.06	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	36.95	6.31	12.62	5.41	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	32.70	13.77	13.77	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	50.32	10.69	14.25	10.69	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	30.50	12.12	13.29	11.73	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	29.03	10.56	10.56	3.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	44.11	17.12	12.45	14.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	29.75	8.31	10.50	7.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	48.08	18.45	18.45	6.71	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	37.10	11.04	8.83	7.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	42.81	10.03	18.13	9.26	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	44.56	9.11	19.75	9.11	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	41.81	12.50	9.13	8.65	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	51.28	8.35	13.91	13.12	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	46.79	11.54	11.54	8.51	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	36.66	11.07	6.92	8.30	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	36.48	12.16	13.30	11.40	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	43.38	13.94	13.94	11.36	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	32.65	7.86	8.47	9.67	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	41.51	9.51	11.41	12.36	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.92	10.66	9.60	12.26	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	40.23	9.77	12.64	7.47	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	38.57	9.77	6.69	8.23	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	25.46	12.03	14.85	4.24	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	37.45	8.51	7.38	7.94	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	33.70	9.15	9.15	4.99	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	29.76	3.92	9.40	6.26	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.57	10.44	10.44	9.19	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.88	5.58	8.36	7.43	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	30.78	4.01	7.36	3.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	38.49	6.95	14.44	6.42	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.69	6.47	13.34	7.27	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	7.34	11.93	6.42	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	30.23	4.45	11.56	8.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	41.03	5.70	13.68	9.12	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	33.74	1.53	6.90	5.37	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	37.21	7.11	9.85	7.11	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	30.29	8.91	10.25	10.25	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	29.63	10.66	11.18	3.12	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	47.08	11.27	11.94	8.62	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	8.31	10.39	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	69.29	27.12	8.20	7.52	0.00
Macrophage - monocyte derived, donor2	11313-117C8	56.70	31.01	11.19	6.24	0.18
Macrophage - monocyte derived, donor3	11389-118C3	41.03	20.32	7.47	6.16	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.02	11.68	4.78	4.25	0.00
Mallassez-derived cells, donor2	11929-125I3	57.04	20.28	9.51	6.18	0.00
Mallassez-derived cells, donor3	11930-125I4	71.86	15.84	14.18	6.53	0.00
Mammary Epithelial Cell, donor1	11273-116H4	95.06	32.78	15.35	11.56	0.00
Mammary Epithelial Cell, donor2	11350-117G9	86.00	27.22	20.56	9.84	0.00
Mammary Epithelial Cell, donor3	11422-118F9	17.21	2.00	6.49	4.24	0.00
Mast cell - stimulated, donor1	11487-119E2	394.56	183.04	85.42	71.18	0.68
Mast cell, donor1	11563-120D6	163.08	76.46	27.79	29.85	0.97
Mast cell, donor2	11565-120D8	172.36	48.44	63.89	40.42	5.94
Mast cell, donor3	11566-120D9	225.35	61.01	81.95	55.61	0.90
Mast cell, donor4	11567-120E1	178.00	40.78	53.72	41.13	6.56
Mast cell, expanded and stimulated, donor5	11940-126A5	165.45	50.12	33.49	18.41	2.44
Mast cell, expanded and stimulated, donor8	11942-126A7	110.90	44.94	26.85	13.42	2.33
Mast cell, expanded, donor5	11939-126A4	152.12	46.69	27.53	16.52	1.84
Mast cell, expanded, donor8	11941-126A6	119.00	48.54	24.10	11.72	1.17
Melanocyte - dark, donor1	11502-119F8	118.10	27.16	13.63	19.60	0.00
Melanocyte - dark, donor2	11582-120F7	58.49	10.38	11.42	7.61	0.00
Melanocyte - dark, donor3	11663-122F7	136.26	33.47	18.04	19.85	0.07
Melanocyte - light, donor1	11274-116H5	23.74	3.06	2.59	2.12	0.47
Melanocyte - light, donor2	11351-117H1	20.47	2.05	4.78	4.09	0.68
Melanocyte - light, donor3	11423-118G1	20.81	0.87	4.34	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	84.55	12.70	10.41	9.68	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	56.21	11.56	11.83	6.19	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	81.16	17.95	11.25	10.98	0.00
Meningeal Cells, donor1	11493-119E8	51.86	7.69	8.31	5.95	0.00
Meningeal Cells, donor2	11573-120E7	34.77	7.92	4.84	3.52	0.00
Meningeal Cells, donor3	11654-122E7	135.21	31.13	26.24	14.02	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	104.37	21.39	23.10	16.54	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	64.81	31.10	13.38	8.45	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	13.14	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	2.62	2.62	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	45.21	10.76	9.33	2.87	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	70.31	21.39	11.01	8.89	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	42.72	14.58	8.04	6.03	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	20.44	4.61	3.96	3.52	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.15	2.92	4.38	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	15.14	2.86	4.71	2.25	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	94.32	32.41	15.10	10.11	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.81	3.35	1.49	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	71.97	21.45	11.18	8.03	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	13.06	5.04	2.67	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	7.01	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.81	1.92	3.84	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	68.76	20.20	15.24	8.51	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	61.61	20.64	8.76	7.19	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	52.25	13.79	12.34	18.87	0.73
Mesothelial Cells, donor1	11247-116E5	60.19	30.50	12.99	10.87	0.00
Mesothelial Cells, donor2	12156-128G5	26.52	13.01	6.01	5.51	0.00
Mesothelial Cells, donor3	11402-118D7	35.19	17.05	8.89	5.20	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	22.96	13.50	6.75	2.70	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	45.31	16.25	7.14	7.63	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.02	19.43	7.36	5.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	58.58	17.98	8.06	10.23	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.03	18.25	7.26	3.11	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	45.05	20.52	6.51	6.76	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.64	15.36	5.59	2.33	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	39.83	18.29	5.08	5.28	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	16.23	16.63	5.94	2.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	29.20	15.93	6.19	3.54	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.14	20.52	7.60	4.18	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	2.63	2.63	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	32.89	15.92	7.64	4.88	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	11.97	5.52	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.55	13.71	3.58	6.56	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	3.35	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	35.13	11.54	4.01	5.27	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.92	14.26	2.14	2.61	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	3.87	3.32	2.76	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	30.85	12.89	4.37	1.84	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.93	13.46	4.42	3.16	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.98	17.53	4.48	4.28	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	35.83	16.09	6.01	5.79	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.67	11.34	1.56	2.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	21.24	11.17	3.94	5.26	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.07	4.56	2.53	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	1.66	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.93	14.40	5.44	3.81	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.82	11.18	3.82	1.18	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	4.36	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	16.34	8.17	3.84	5.29	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.41	10.41	5.20	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	12.34	2.74	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10.51	12.01	4.00	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	6.12	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19.71	18.83	3.50	5.26	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	2.21	1.10	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	6.40	2.56	1.92	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	27.27	17.11	5.45	3.72	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	6.26	4.18	2.78	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	29.40	18.46	5.81	3.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	5.69	0.88	1.75	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	4.97	2.13	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	26.65	13.47	5.61	3.09	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.22	9.14	4.16	2.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	2.91	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	20.51	10.56	4.22	3.02	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.95	13.36	5.84	4.17	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	26.78	11.08	4.62	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.35	11.38	2.28	2.85	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.76	9.81	2.90	2.49	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	26.69	9.85	4.92	3.37	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.02	12.44	6.01	3.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	5.08	3.18	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.75	11.21	4.00	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.53	16.46	5.39	6.59	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	15.40	10.31	3.39	2.97	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.98	14.33	4.78	4.14	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	25.87	18.80	6.86	5.97	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.24	6.07	4.17	1.90	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	38.64	15.06	8.81	4.55	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	36.38	14.01	5.41	5.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.08	8.47	1.96	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	36.17	11.47	5.00	3.53	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	36.04	16.72	7.78	6.34	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	35.44	25.14	7.83	5.36	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.42	12.80	5.96	5.06	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	15.07	0.00	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	10.69	5.35	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	67.03	11.17	6.90	5.91	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	35.77	16.83	5.26	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	86.78	19.77	12.45	8.50	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	39.12	16.76	4.66	4.66	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	58.96	22.53	7.51	5.26	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	27.43	11.99	8.26	5.59	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	61.75	21.38	6.90	5.77	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	36.10	11.79	6.63	2.21	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	50.20	12.09	7.69	5.13	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	45.11	17.11	3.11	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	55.58	17.10	3.74	3.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	0.00	3.86	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	51.51	13.13	9.09	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	32.47	19.40	4.22	2.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	46.31	13.62	0.00	2.72	5.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	22.25	14.62	3.81	1.91	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	19.44	15.39	3.24	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	12.08	3.02	4.53	7.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	91.36	22.84	11.42	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	163.12	42.41	16.31	22.84	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	4.75	0.00	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	25.10	12.55	25.10
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	80.57	20.68	14.43	8.19	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	68.98	18.81	12.54	6.27	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.70	6.01	12.01	8.01	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.11	0.83	13.36	7.93	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	88.23	15.59	27.57	15.21	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	47.88	17.55	11.17	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	23.80	6.12	8.16	4.76	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	64.32	11.03	16.54	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	38.51	5.86	8.37	6.28	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	54.62	9.99	16.50	9.76	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	45.13	6.76	13.78	6.22	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	56.55	14.72	13.46	9.67	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	244.96	44.54	33.40	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	49.64	10.42	8.44	4.96	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	56.84	12.18	10.83	6.77	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	44.43	11.33	10.43	6.57	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	39.03	7.02	11.92	6.86	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	59.23	15.67	9.84	9.30	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	37.13	15.38	7.96	7.43	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	33.02	9.60	11.41	4.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	66.95	19.69	17.39	11.16	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	39.35	10.73	8.78	7.32	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	51.86	19.05	8.64	8.11	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	44.30	11.25	10.55	12.66	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	40.45	14.25	13.33	6.90	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	49.49	14.78	9.32	11.57	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	91.74	21.73	11.38	10.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	93.55	27.81	10.11	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.44	12.92	10.03	7.13	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.02	4.66	11.85	9.74	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	64.08	14.24	14.00	10.92	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	71.26	13.31	20.60	12.88	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	72.22	27.08	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	47.32	9.66	9.66	8.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	36.07	10.37	10.37	5.41	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.16	13.09	9.92	6.75	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	63.15	13.93	16.72	3.71	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	90.81	17.78	18.92	12.86	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	43.67	12.06	15.32	7.50	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	30.07	6.97	10.02	3.05	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	38.90	20.35	9.05	4.52	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	48.50	10.58	11.46	7.94	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	70.47	9.97	12.63	10.64	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	63.00	13.39	8.43	9.42	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	34.07	14.16	8.42	4.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	109.49	23.29	16.33	19.36	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	37.57	21.88	10.17	6.63	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	43.37	14.23	8.81	4.07	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	56.20	35.77	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	78.65	9.75	15.85	8.54	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	30.84	11.02	13.22	8.50	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	48.12	8.17	8.17	6.96	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	58.54	12.66	8.70	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	78.22	15.87	14.74	6.80	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	161.85	40.46	10.12	10.12	0.00
Myoblast, donor1	11241-116D8	45.72	22.49	12.80	8.70	0.00
Myoblast, donor2	11322-117D8	47.37	15.92	11.89	6.90	0.00
Myoblast, donor3	11398-118D3	77.52	32.79	21.36	15.30	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	96.75	13.28	11.67	10.65	0.29
Natural Killer Cells, donor1	11230-116C6	246.63	80.26	55.35	44.28	0.00
Natural Killer Cells, donor2	11311-117C6	160.43	60.61	47.95	48.25	0.00
Natural Killer Cells, donor3	11387-118C1	195.28	54.30	44.17	57.61	0.18
Neural stem cells, donor1	11275-116H6	300.15	77.67	60.25	28.67	0.36
Neural stem cells, donor2	11352-117H2	390.91	157.90	77.03	65.47	0.00
Neurons, donor1	11494-119E9	261.72	105.82	59.17	28.45	0.00
Neurons, donor2	11574-120E8	342.13	126.59	78.82	40.07	0.00
Neurons, donor3	11655-122E8	367.51	89.62	81.39	61.66	0.00
Neutrophils, donor1	11233-116C9	108.58	25.06	41.76	17.63	0.00
Neutrophils, donor2	11314-117C9	43.48	14.49	40.58	14.49	0.00
Neutrophils, donor3	11390-118C4	149.05	37.26	67.19	35.43	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	121.23	28.85	19.24	13.65	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	41.68	12.70	12.05	2.93	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	61.77	12.84	6.82	7.62	0.00
Olfactory epithelial cells, donor1	11933-125I7	63.87	14.87	15.00	9.77	0.41
Olfactory epithelial cells, donor2	11934-125I8	75.70	21.71	16.65	9.41	0.29
Olfactory epithelial cells, donor3	11935-125I9	63.79	16.91	12.94	7.49	0.00
Olfactory epithelial cells, donor4	11936-126A1	64.87	15.49	13.73	6.04	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	84.86	20.46	15.05	18.05	0.00
Osteoblast - differentiated, donor1	11276-116H7	47.01	13.19	14.04	2.77	0.00
Osteoblast - differentiated, donor2	11353-117H3	11.43	10.29	5.72	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	37.86	4.34	4.34	1.86	0.00
Osteoblast, donor1	11277-116H8	25.02	2.15	5.47	3.13	0.00
Osteoblast, donor2	11354-117H4	105.35	28.09	20.37	18.26	0.00
Osteoblast, donor3	11426-118G4	25.77	6.40	5.87	4.44	0.00
Pancreatic stromal cells, donor1	11249-116E7	88.36	25.02	11.37	11.62	0.00
Pericytes, donor1	11491-119E6	11.13	3.45	2.11	1.22	0.00
Pericytes, donor2	11571-120E5	13.58	2.72	2.72	2.72	0.00
Pericytes, donor3	11652-122E5	11.39	2.44	6.31	0.81	0.00
Perineurial Cells, donor1	11499-119F5	105.22	29.72	20.34	15.14	0.00
Perineurial Cells, donor2	11579-120F4	116.12	23.37	17.30	21.44	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	220.57	61.52	59.60	29.01	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	118.51	31.59	37.95	28.40	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	132.00	35.85	34.42	29.25	0.13
Placental Epithelial Cells, donor1	11278-116H9	51.42	3.83	8.13	4.07	0.00
Placental Epithelial Cells, donor2	11355-117H5	31.05	6.65	5.54	2.22	0.00
Placental Epithelial Cells, donor3	11427-118G5	21.99	3.34	2.75	3.53	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.09	8.54	4.75	2.22	0.00
Preadipocyte - breast, donor1	11467-119B9	43.90	28.51	17.63	4.13	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	211.58	35.50	28.98	28.06	0.00
Preadipocyte - breast, donor2	11328-117E5	46.16	13.06	10.58	5.63	0.00
Preadipocyte - omental, donor1	11468-119C1	68.30	30.37	17.26	6.39	0.00
Preadipocyte - omental, donor2	11329-117E6	78.56	21.82	17.90	8.73	0.00
Preadipocyte - omental, donor3	11403-118D8	53.86	18.19	12.61	8.59	0.00
Preadipocyte - perirenal, donor1	11469-119C2	20.67	5.91	12.80	4.92	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	27.03	4.91	8.91	2.46	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	78.27	14.17	13.46	9.03	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	56.53	15.50	6.81	5.28	0.00
Preadipocyte - visceral, donor1	11280-116I2	83.55	25.71	17.60	7.82	0.09
Preadipocyte - visceral, donor2	11357-117H7	57.06	17.95	12.42	6.90	0.00
Preadipocyte - visceral, donor3	11429-118G7	56.95	12.02	12.33	9.93	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	118.72	23.08	23.38	19.91	0.00
Prostate Epithelial Cells, donor2	11331-117E8	27.35	10.83	9.89	5.55	0.00
Prostate Epithelial Cells, donor3	11404-118D9	42.19	5.14	5.14	5.88	0.00
Prostate Stromal Cells, donor1	11254-116F3	55.47	12.98	15.72	7.97	0.00
Prostate Stromal Cells, donor2	11332-117E9	55.94	10.76	11.48	9.50	0.00
Prostate Stromal Cells, donor3	11405-118E1	51.93	11.78	6.36	6.88	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	16.06	5.11	2.55	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	70.14	18.58	20.10	10.88	0.00
Renal Epithelial Cells, donor1	11517-119H5	16.23	1.52	5.07	2.54	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	1.42	0.71	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	84.16	26.47	24.56	9.63	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.00	2.72	2.72	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	17.52	1.89	4.31	2.43	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	62.83	15.32	15.10	8.88	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	0.67	2.00	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	17.61	4.62	4.40	1.10	0.00
Renal Mesangial Cells, donor2	11598-120H5	6.90	3.13	6.27	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.72	0.83	0.55	1.94	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	23.08	4.29	4.56	2.68	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.86	0.84	2.95	1.69	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.34	3.28	3.09	2.31	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	96.19	29.30	15.04	14.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.19	5.40	3.41	1.99	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	1.03	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	58.96	30.11	14.30	4.01	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	144.59	24.19	18.98	17.24	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	67.90	26.80	13.40	8.04	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	179.42	49.53	19.81	20.36	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	72.51	39.44	15.66	9.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	191.01	37.71	23.01	17.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	92.16	20.66	16.58	12.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	163.07	45.84	26.55	17.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	214.47	31.76	23.57	26.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	103.96	25.29	16.08	12.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	112.56	34.67	16.41	13.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	126.23	24.64	14.92	14.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	104.08	22.84	14.07	11.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	127.23	32.25	17.92	17.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	128.39	23.96	12.05	12.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	111.39	20.28	15.56	12.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	111.74	29.87	17.04	14.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	129.04	24.66	9.56	10.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	101.08	21.99	16.40	11.74	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	148.26	49.98	28.00	16.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	117.31	24.15	11.28	15.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	91.31	22.00	13.04	13.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	110.95	29.79	16.42	15.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	129.65	22.43	12.71	18.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	102.59	21.86	12.33	9.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	89.55	24.78	14.70	11.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	108.67	22.97	11.12	11.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	89.15	22.56	17.29	12.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	105.71	27.27	14.78	14.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	180.68	35.15	14.86	16.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	95.04	22.22	13.49	15.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	126.98	29.70	14.73	14.97	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	146.60	29.24	14.51	14.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	96.67	26.99	16.59	11.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	75.20	24.65	15.88	9.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	132.43	26.65	13.86	14.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	84.13	24.01	13.45	10.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	89.65	27.18	16.97	13.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	156.46	27.17	14.10	15.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	78.19	21.40	11.80	10.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	97.35	34.64	16.09	15.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	134.64	28.46	12.78	12.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	110.23	30.18	14.65	15.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	81.83	21.32	11.99	15.46	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	138.54	27.52	11.89	11.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	95.00	26.91	10.95	13.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	88.48	32.65	15.12	15.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	131.00	22.88	11.02	15.44	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	116.69	29.70	12.93	12.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	80.39	30.52	12.69	14.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	134.87	22.76	14.32	17.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	211.05	64.77	26.64	21.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	101.00	30.42	12.17	14.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	157.33	24.41	14.47	12.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	94.32	21.04	12.44	12.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	116.52	32.05	16.18	20.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	164.36	28.22	16.18	14.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	85.38	22.63	12.17	12.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	95.56	39.06	13.82	14.42	0.00
Schwann Cells, donor1	11498-119F4	14.29	2.63	3.39	3.01	0.19
Schwann Cells, donor2	11578-120F3	85.06	13.61	0.00	17.01	0.00
Schwann Cells, donor3	11659-122F3	66.82	21.91	19.50	12.71	0.00
Sebocyte, donor1	11220-116B5	37.25	4.93	8.22	4.38	0.00
Sebocyte, donor2	11301-117B5	11.95	2.30	3.22	1.38	0.00
Sebocyte, donor3	11378-118B1	14.43	1.86	3.30	1.65	0.00
Sertoli Cells, donor1	11255-116F4	76.20	26.51	19.88	6.63	0.00
Sertoli Cells, donor2	11333-117F1	48.01	19.77	11.30	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	67.92	14.96	9.24	5.98	0.00
Skeletal Muscle Cells, donor2	11358-117H8	8.67	2.17	0.72	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	25.92	5.85	10.87	2.51	0.84
Skeletal Muscle Cells, donor4	11451-119A2	90.80	16.97	17.12	14.45	0.00
Skeletal Muscle Cells, donor5	11455-119A6	79.67	16.50	16.05	13.23	0.00
Skeletal Muscle Cells, donor6	11459-119B1	107.12	15.85	20.78	20.47	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	124.62	32.13	19.28	14.49	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	66.06	20.69	15.55	8.99	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	87.50	17.46	18.45	14.88	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	69.84	17.61	14.83	8.43	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.75	2.17	5.79	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	31.65	3.99	7.98	6.05	0.00
Skin - palm, donor1	10286-104F7	34.92	16.12	16.12	5.37	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.20	7.93	10.24	4.32	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	96.51	20.45	22.90	17.18	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.87	4.67	10.00	4.54	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	32.39	19.04	11.95	3.89	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	20.96	5.34	4.78	4.08	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	152.03	16.70	32.77	35.31	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	22.04	5.32	6.30	3.82	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.76	16.35	10.80	2.47	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	108.05	24.46	15.12	14.90	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	34.09	12.34	7.64	4.70	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	32.93	5.52	6.63	3.09	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.14	4.73	3.54	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	63.35	9.27	7.73	5.41	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	74.06	17.01	10.01	11.01	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	38.99	9.98	9.71	5.46	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	52.31	23.27	11.08	6.65	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.93	13.44	13.70	6.27	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	66.75	22.79	11.07	9.44	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	93.03	27.47	18.61	18.01	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.35	10.82	7.69	5.27	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	0.81	1.63	1.14	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	45.66	7.61	5.48	5.78	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	46.22	5.56	8.59	4.04	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	6.12	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.17	1.43	4.29	3.81	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	51.47	18.29	12.54	6.05	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.20	13.99	9.47	3.87	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	51.11	10.60	8.92	9.34	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.94	4.18	5.88	2.63	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	5.39	6.47	7.55	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	21.82	6.28	5.08	3.89	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	12.63	1.71	2.73	1.71	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	108.13	26.31	14.61	9.50	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	52.23	33.71	18.62	7.65	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	39.82	10.01	10.47	8.42	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	0.60	1.81	2.42	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	132.99	24.11	35.50	26.49	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	136.89	16.91	19.04	14.25	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	51.72	16.40	8.77	9.89	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	55.81	18.26	7.86	5.58	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	64.83	17.19	13.12	8.14	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	6.00	4.50	3.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	9.05	3.88	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	41.39	11.16	7.91	4.65	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	21.71	7.07	6.56	6.06	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	20.37	6.89	10.97	5.33	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.42	2.36	1.77	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	108.30	23.24	19.91	18.41	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.17	10.74	6.07	7.01	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.29	3.89	5.32	3.02	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	26.52	7.14	5.61	5.61	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.62	2.26	6.02	3.01	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	111.80	26.55	19.42	20.54	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	71.72	19.44	10.64	12.07	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	1.43	1.90	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.59	2.94	3.91	2.20	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	74.46	28.06	16.79	12.15	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	102.99	13.46	12.00	12.58	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	43.34	18.27	5.05	3.89	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	28.30	15.34	6.08	3.17	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	71.79	29.38	5.95	6.32	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	35.22	22.28	10.06	5.03	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	22.14	12.78	7.67	2.27	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	77.99	18.91	10.24	6.70	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	39.87	17.78	5.33	3.56	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	53.91	9.58	6.79	1.20	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	45.56	15.88	3.76	4.60	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	52.71	14.21	8.71	7.79	0.00
Synoviocyte, donor1	11291-117A4	55.38	25.92	15.32	6.06	0.34
Synoviocyte, donor2	11368-117I9	55.15	13.24	6.70	6.37	0.00
Synoviocyte, donor3	11440-118H9	64.12	12.96	4.69	5.81	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	30.37	4.29	3.22	3.93	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	22.69	2.78	4.17	3.24	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	39.86	8.89	5.52	4.66	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	17.40	2.32	3.09	4.25	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	21.19	2.86	5.15	2.29	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	146.64	26.20	18.95	18.95	0.37
Urethra, donor2	10319-105A4	53.95	7.19	8.99	5.40	1.80
Urothelial Cells, donor1	11520-119H8	4.78	1.86	3.19	0.80	0.00
Urothelial Cells, donor2	11600-120H7	2.40	1.20	4.41	0.80	0.00
Urothelial Cells, donor3	11681-122H7	3.90	0.69	1.60	0.92	0.00
Urothelial cells, donor0	11216-116B1	48.37	18.95	9.81	6.02	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	219.78	48.94	33.81	24.02	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	203.00	68.62	31.45	28.59	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.08	24.64	19.17	9.58	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	131.88	33.75	25.14	10.67	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	128.41	38.93	20.92	8.72	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	173.89	52.06	35.40	14.58	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	244.13	61.49	32.12	13.77	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	80.34	22.82	18.26	9.13	0.00
Wilms' tumor cell line:G-401	10809-111A8	122.62	34.05	23.07	17.27	1.36
Wilms' tumor cell line:HFWT	10597-108E3	33.44	10.56	12.32	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	81.56	8.10	19.83	10.06	0.28
achilles tendon, donor2	10292-104G4	57.86	10.33	2.07	2.07	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	184.08	55.07	31.36	33.65	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	286.97	43.88	37.38	33.67	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	229.94	55.91	33.36	31.58	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	208.98	97.69	43.27	45.44	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	153.47	18.27	16.58	14.34	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	84.80	27.92	14.38	10.15	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	95.00	45.73	19.60	14.97	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	133.95	38.78	22.47	21.59	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	132.72	41.65	17.97	17.97	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	144.06	38.05	23.69	17.47	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	119.05	35.33	20.42	12.88	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	152.12	62.41	23.40	27.30	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	147.10	45.31	24.86	21.15	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	150.16	41.68	24.60	13.72	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	125.96	41.50	18.70	12.27	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	66.00	18.13	6.04	6.97	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	77.32	29.61	11.52	6.58	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	75.51	11.36	21.49	14.73	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	190.74	28.16	32.86	23.47	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	180.76	46.71	27.90	24.87	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	205.56	42.12	28.40	18.53	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	89.99	25.17	17.37	10.69	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	92.06	29.02	8.01	7.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	37.16	31.59	14.87	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	77.59	24.48	20.72	16.95	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	91.59	75.89	17.01	9.16	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	73.10	22.49	11.25	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	97.26	13.66	13.42	12.72	0.24
adipose tissue, adult, pool1	10010-101C1	113.55	19.08	17.68	11.17	0.00
adipose, donor1	10184-103D4	372.96	73.89	62.75	67.44	0.59
adipose, donor2	10185-103D5	130.17	42.98	28.79	19.87	0.00
adipose, donor3	10186-103D6	158.74	56.36	32.13	26.96	0.00
adipose, donor4	10187-103D7	213.22	46.80	28.60	37.27	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	90.90	40.88	32.35	19.25	0.00
adrenal gland, adult, pool1	10081-102A9	40.01	21.83	3.64	14.55	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	101.26	23.88	17.08	8.14	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	153.28	20.72	24.65	14.29	18.94
amniotic membrane cells, donor1	12235-129G3	92.51	25.74	19.94	15.53	0.00
amniotic membrane cells, donor2	12236-129G4	117.32	19.61	19.61	24.01	0.00
amniotic membrane cells, donor3	12237-129G5	68.94	33.29	15.61	15.02	0.00
amygdala - adult, donor10196	10167-103B5	145.85	225.30	61.66	26.09	8.30
amygdala, adult, donor10252	10151-102I7	112.13	104.63	43.80	26.16	5.07
amygdala, newborn, donor10223	10360-105E9	76.17	122.33	48.09	15.17	40.02
anaplastic carcinoma cell line:8305C	10428-106D5	80.73	21.52	14.13	11.97	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	110.31	44.35	23.61	20.08	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	193.07	41.09	24.38	27.73	0.00
aorta, adult, pool1	10052-101G7	93.75	10.79	15.49	14.32	0.00
appendix, adult	10189-103D9	128.86	17.08	20.57	11.64	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	159.24	57.44	20.29	13.41	0.00
artery, adult	10190-103E1	84.24	12.23	16.30	8.15	0.00
astrocytoma cell line:TM-31	10425-106D2	164.71	29.99	10.87	10.43	0.14
b cell line:RPMI1788	10427-106D4	125.50	35.99	23.94	13.83	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	72.97	24.42	23.31	8.60	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	95.06	32.05	11.61	10.22	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	123.19	27.12	10.54	12.39	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	67.67	22.37	11.74	6.71	0.00
bladder, adult, pool1	10011-101C2	138.95	15.97	21.95	16.30	0.00
blood, adult, pool1	10053-101G8	93.01	13.29	17.72	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	58.23	18.84	5.14	3.43	0.86
bone marrow, adult	10192-103E3	75.58	30.37	17.55	10.12	0.00
brain, adult, donor1	10084-102B3	93.28	73.80	34.85	20.50	2.05
brain, adult, pool1	10012-101C3	177.51	180.29	57.02	26.50	8.02
brain, fetal, pool1	10085-102B4	120.21	112.20	53.43	24.04	0.00
breast carcinoma cell line:MCF7	10482-107A5	39.97	25.11	15.86	8.26	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	109.84	25.59	28.71	16.48	0.37
breast, adult, donor1	10080-102A8	111.75	10.10	20.83	18.31	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	103.79	18.17	10.93	13.85	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	103.28	23.81	15.77	12.06	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	150.79	49.27	44.89	24.86	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	83.52	32.92	15.98	11.62	0.00
carcinoid cell line:NCI-H1770	10703-109H1	112.84	21.63	24.45	16.93	0.00
carcinoid cell line:NCI-H727	10735-110B6	95.27	22.64	10.39	9.30	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	118.20	38.34	28.20	17.43	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	218.80	35.67	28.48	18.63	0.00
caudate nucleus - adult, donor10196	10177-103C6	140.46	208.39	49.51	27.63	17.27
caudate nucleus, adult, donor10252	10164-103B2	121.31	135.20	45.51	27.94	2.34
caudate nucleus, adult, donor10258	10379-105H1	133.72	236.88	70.30	12.99	11.46
caudate nucleus, newborn, donor10223	10354-105E3	92.66	153.09	41.75	13.55	31.50
cerebellum - adult, donor10196	10173-103C2	404.94	215.58	90.31	46.61	0.00
cerebellum, adult, donor10252	10166-103B4	343.54	132.59	60.64	40.78	1.28
cerebellum, adult, pool1	10083-102B2	231.11	77.61	35.87	26.91	0.69
cerebellum, newborn, donor10223	10357-105E6	170.21	125.37	48.99	11.62	2.49
cerebral meninges, adult	10188-103D8	117.75	137.42	43.62	17.90	5.04
cerebrospinal fluid, donor2	10294-104G6	38.01	14.62	8.77	5.12	0.00
cervical cancer cell line:D98-AH2	10552-107I3	157.30	52.05	17.54	12.80	0.86
cervical cancer cell line:ME-180	10553-107I4	89.32	21.54	10.61	11.43	0.00
cervix, adult, pool1	10013-101C4	185.94	23.41	27.93	20.47	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	126.10	42.64	22.43	20.20	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	13.06	9.14	2.61	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	160.32	43.25	24.86	15.78	0.00
choriocarcinoma cell line:SCH	10785-110H2	111.38	25.50	16.14	22.18	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	64.04	18.74	8.78	13.52	0.47
chorionic membrane cells, donor1	12238-129G6	81.77	15.96	18.80	13.11	0.00
chorionic membrane cells, donor2	12239-129G7	92.57	12.43	11.34	16.70	0.20
chorionic membrane cells, donor3	12240-129G8	99.46	15.39	10.99	6.04	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	126.23	44.43	13.13	9.09	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	145.03	34.00	17.29	19.59	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	93.34	24.92	17.11	13.09	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	119.16	15.66	15.41	12.33	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	116.34	22.49	17.17	12.82	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	116.26	13.64	15.07	8.76	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	193.46	32.39	33.27	20.32	2.65
chronic myelogenous leukemia cell line:KU812	10409-106B4	201.72	51.60	33.62	19.81	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	92.80	23.09	15.77	11.89	0.00
clear cell carcinoma cell line:TEN	10636-108I6	154.94	44.24	23.94	25.16	0.35
colon carcinoma cell line:CACO-2	10513-107D9	148.81	35.51	25.08	34.05	7.32
colon carcinoma cell line:COLO-320	10420-106C6	269.10	17.86	29.65	19.00	0.38
colon, adult, donor1	10082-102B1	77.35	5.95	8.33	9.52	0.00
colon, adult, pool1	10014-101C5	137.71	13.87	17.04	12.10	0.00
colon, fetal, donor1	10070-101I7	117.42	16.69	25.34	16.07	0.00
common myeloid progenitor CMP, donor1	12130-128D6	146.67	27.50	41.25	27.50	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07	75.11	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	218.84	57.37	32.29	21.25	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	126.93	38.34	19.32	14.04	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	170.91	40.75	25.81	14.38	0.99
corpus callosum, adult, pool1	10042-101F6	155.34	64.68	38.81	22.44	1.33
cruciate ligament, donor2	10295-104G7	68.89	8.92	9.73	6.48	0.81
diaphragm, fetal, donor1	10069-101I6	101.93	9.63	10.43	16.85	0.00
diencephalon, adult	10193-103E4	113.99	98.16	25.68	16.80	4.80
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	146.72	35.59	28.24	25.72	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	106.42	38.47	17.44	12.57	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	79.68	21.18	27.44	24.31	0.24
ductus deferens, adult	10196-103E7	118.60	22.43	11.96	11.96	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	135.38	31.69	24.48	30.24	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	136.83	25.75	14.71	16.18	0.00
dura mater, adult, donor1	10041-101F5	146.43	33.53	26.43	21.31	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	190.54	85.50	33.09	31.53	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	134.84	47.57	35.82	18.91	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	36.38	6.78	4.93	3.70	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	58.42	11.81	9.38	5.15	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	49.71	13.28	8.64	5.87	0.00
embryonic pancreas cell line:2C6	10603-108E9	45.97	10.51	1.31	5.25	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	66.03	33.52	24.47	13.41	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	135.56	27.91	21.02	13.96	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	52.10	18.33	13.51	11.10	0.00
epidermoid carcinoma cell line:A431	10426-106D3	56.91	23.45	12.34	8.23	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	94.92	22.77	19.91	12.98	0.44
epididymis, adult	10197-103E8	111.35	21.77	15.91	10.47	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	114.96	25.37	21.11	11.89	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	42.47	11.80	8.26	5.51	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	136.95	29.75	21.89	24.24	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	138.87	27.36	17.91	24.41	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	138.80	32.49	20.17	28.01	0.11
esophagus, adult, pool1	10015-101C6	116.37	14.23	12.42	11.25	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	163.18	58.11	41.45	17.66	0.63
eye - muscle inferior rectus, donor1	10272-104E2	67.61	9.66	7.24	14.49	0.00
eye - muscle lateral, donor2	10298-104H1	33.67	16.83	8.42	4.21	0.00
eye - muscle medial, donor2	10299-104H2	46.13	4.46	7.44	1.49	0.00
eye - muscle superior, donor2	10297-104G9	30.96	11.46	10.32	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	45.18	21.86	8.74	7.29	0.00
eye, fetal, donor1	10054-101G9	191.69	53.90	23.14	21.86	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	87.83	19.36	11.41	11.41	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	113.72	24.45	22.08	15.67	0.00
frontal lobe, adult, pool1	10040-101F4	189.43	263.27	88.76	33.87	17.26
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	202.97	59.15	25.22	24.62	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	87.78	39.23	15.73	9.88	0.00
gall bladder, adult	10198-103E9	65.19	11.35	9.17	8.93	0.00
gamma delta positive T cells, donor1	11937-126A2	249.64	53.69	34.90	22.55	0.00
gamma delta positive T cells, donor2	11938-126A3	228.95	61.25	38.84	28.01	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	93.15	31.47	16.26	13.73	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	66.34	18.95	7.16	10.44	0.00
gastric cancer cell line:AZ521	10549-107H9	160.02	45.74	25.74	19.84	0.00
gastric cancer cell line:GSS	10560-108A2	115.32	20.13	13.73	6.41	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	161.52	36.78	23.53	29.01	0.46
giant cell carcinoma cell line:LU65	10487-107B1	106.36	32.82	29.03	12.74	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	95.87	27.29	21.55	17.91	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	61.36	19.70	6.98	4.74	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	75.05	24.49	11.51	7.60	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	78.36	23.73	13.90	9.69	0.42
glioblastoma cell line:T98G	10485-107A8	113.02	17.88	25.39	15.78	0.33
glioma cell line:GI-1	10413-106B8	105.14	34.85	13.18	15.23	0.00
globus pallidus - adult, donor10196	10175-103C4	140.68	143.60	40.82	13.12	5.83
globus pallidus, adult, donor10252	10161-103A8	151.58	80.80	38.57	34.66	1.22
globus pallidus, adult, donor10258	10367-105F7	76.68	93.11	36.97	12.32	5.48
globus pallidus, newborn, donor10223	10364-105F4	64.48	85.27	30.38	13.32	10.66
granulocyte macrophage progenitor, donor1	12131-128D7	139.49	24.47	34.26	24.47	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	32.79	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	10.45	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	44.16	11.84	9.92	6.72	0.32
hIPS +CCl2, biol_rep1	14383-156B9	190.07	89.99	28.92	19.28	0.00
hIPS +CCl2, biol_rep2	14384-156C1	183.36	91.91	22.41	16.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	158.45	83.73	20.61	16.75	0.00
hIPS, biol_rep1	14380-156B6	178.22	97.74	7.19	12.94	0.00
hIPS, biol_rep2	14381-156B7	178.33	84.36	15.77	21.26	0.00
hIPS, biol_rep3	14382-156B8	158.90	145.66	28.69	7.72	7.72
hairy cell leukemia cell line:Mo	10712-109I1	102.01	43.39	31.32	19.25	0.29
heart - mitral valve, adult	10205-103F7	101.95	21.23	14.35	14.65	0.00
heart - pulmonic valve, adult	10206-103F8	93.35	20.92	14.64	6.28	0.00
heart - tricuspid valve, adult	10207-103F9	82.43	20.82	15.82	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	75.09	13.67	10.81	11.02	0.00
heart, adult, diseased, donor1	10051-101G6	106.88	9.79	9.79	12.77	0.00
heart, adult, pool1	10016-101C7	107.17	14.95	6.44	5.75	0.00
heart, fetal, pool1	10046-101G1	225.90	27.31	30.70	21.87	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	50.60	15.12	8.02	8.02	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	33.30	17.84	14.27	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	134.03	27.07	21.88	32.26	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	142.49	33.26	20.63	32.77	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	147.74	34.56	24.15	34.36	0.00
hepatoma cell line:Li-7	10484-107A7	129.57	28.25	9.34	13.79	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	108.54	22.11	18.79	17.29	1.31
hippocampus - adult, donor10196	10169-103B7	141.95	175.07	42.58	24.60	4.73
hippocampus, adult, donor10252	10153-102I9	126.34	84.91	39.19	24.90	4.69
hippocampus, adult, donor10258	10374-105G5	157.35	241.51	29.88	20.42	12.95
hippocampus, newborn, donor10223	10363-105F3	72.26	154.03	40.89	11.28	11.63
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	245.97	128.17	45.78	36.01	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	121.74	60.87	33.77	22.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	119.58	69.31	35.29	21.07	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	140.97	34.96	33.83	16.92	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	203.99	29.44	30.73	24.53	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	165.13	42.14	36.82	19.36	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	166.71	48.17	26.86	14.01	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	169.33	49.98	27.57	22.40	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	135.55	48.80	24.61	15.85	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	268.76	113.19	37.65	28.42	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	212.95	67.66	27.48	21.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	278.07	101.67	35.69	29.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	129.73	68.38	35.21	30.83	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	173.92	75.66	30.46	26.53	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	184.15	124.80	48.87	24.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	204.47	46.01	41.24	31.69	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	203.65	40.12	35.76	26.16	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	238.89	55.47	42.98	34.48	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	143.93	55.58	28.45	20.91	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	187.34	65.48	30.47	23.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	125.92	48.55	30.70	15.66	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	152.52	91.12	24.33	23.19	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	148.64	99.29	19.74	20.61	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	122.26	79.21	22.42	14.05	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	130.98	72.97	34.92	24.57	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	151.49	67.61	32.52	31.38	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	193.13	93.50	41.65	33.07	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	183.43	37.32	23.94	21.12	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	150.77	41.81	24.39	16.79	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	126.50	35.41	26.33	14.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	145.83	58.43	19.65	14.48	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	145.45	63.10	21.25	28.56	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	87.99	57.46	14.88	10.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	170.01	76.69	23.52	23.78	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	149.93	96.17	22.72	25.75	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	143.50	78.97	25.54	15.12	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	150.94	73.42	34.78	26.57	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	127.46	82.00	33.87	18.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	151.71	80.00	38.54	27.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	145.78	42.48	32.70	30.56	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	894.64	292.79	110.61	130.13	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	186.65	49.97	41.04	23.50	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	163.64	72.79	20.80	14.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	140.41	50.30	23.16	10.49	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	145.20	44.13	23.13	12.46	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	161.11	65.64	36.99	16.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	325.43	120.93	41.30	31.82	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	146.28	48.76	24.51	12.12	0.00
immature langerhans cells, donor1	11904-125F5	94.19	89.11	24.94	15.98	0.00
immature langerhans cells, donor2	11905-125F6	49.11	38.81	18.22	9.51	0.00
insula, adult, pool1	10039-101F3	138.26	153.02	68.99	22.90	15.14
keratoacanthoma cell line:HKA-1	10791-110H8	74.13	14.96	8.78	8.78	0.33
kidney, adult, pool1	10017-101C8	128.46	27.33	22.63	13.42	0.00
kidney, fetal, pool1	10045-101F9	121.45	20.09	28.79	18.53	0.42
large cell lung carcinoma cell line:IA-LM	10509-107D5	161.90	99.27	27.27	22.30	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	71.61	24.05	8.57	9.40	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.83	8.99	8.62	5.87	0.00
left atrium, adult, donor1	10079-102A7	108.43	8.72	7.63	9.81	0.00
left ventricle, adult, donor1	10078-102A6	92.03	11.12	7.08	11.12	0.00
leiomyoblastoma cell line:G-402	10721-110A1	89.74	13.95	20.52	15.60	0.00
leiomyoma cell line:10964C	10569-108B2	21.55	5.39	6.83	3.23	0.00
leiomyoma cell line:15242A	10570-108B3	27.17	11.41	6.52	3.80	0.00
leiomyoma cell line:15425	10571-108B4	35.94	12.14	6.56	6.80	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	12.70	6.35	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	59.60	9.41	23.00	8.36	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	126.68	54.90	24.08	23.02	0.12
liposarcoma cell line:KMLS-1	10782-110G8	54.52	19.21	13.90	8.59	0.00
liposarcoma cell line:SW 872	10726-110A6	76.64	19.86	12.18	11.45	0.37
liver, adult, pool1	10018-101C9	78.76	14.59	8.10	6.48	0.00
liver, fetal, pool1	10086-102B5	51.74	6.58	3.76	9.41	0.00
locus coeruleus - adult, donor10196	10182-103D2	86.62	73.50	43.89	16.48	2.77
locus coeruleus, adult, donor10252	10165-103B3	105.75	76.59	37.83	24.91	2.58
locus coeruleus, adult, donor10258	10375-105G6	124.42	78.15	41.47	18.62	5.64
locus coeruleus, newborn, donor10223	10362-105F2	112.31	108.52	29.44	14.72	8.83
lung adenocarcinoma cell line:A549	10499-107C4	59.51	16.19	6.64	6.78	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	44.12	6.89	11.03	6.89	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	65.25	18.32	10.68	9.36	0.00
lung, adult, pool1	10019-101D1	114.11	13.82	23.15	15.24	0.12
lung, fetal, donor1	10068-101I5	350.48	70.50	53.66	30.54	0.00
lung, right lower lobe, adult, donor1	10075-102A3	114.55	17.41	18.79	15.58	0.00
lymph node, adult, donor1	10077-102A5	106.98	20.35	15.15	17.04	0.00
lymphangiectasia cell line:DS-1	10727-110A7	113.31	25.86	14.68	15.34	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	232.88	58.71	32.00	38.64	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	98.54	54.37	11.89	11.04	0.00
mature adipocyte, donor1	12231-129F8	93.68	27.08	15.98	13.32	0.00
mature adipocyte, donor2	12232-129F9	100.65	20.96	12.45	10.58	0.00
mature adipocyte, donor3	12233-129G1	99.33	32.00	11.38	9.96	0.00
mature adipocyte, donor4	12234-129G2	97.39	30.53	13.42	11.58	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	129.14	28.83	17.15	11.91	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	165.82	249.29	69.94	21.43	16.92
medial frontal gyrus, adult, donor10252	10150-102I6	154.85	113.84	52.05	30.90	11.59
medial frontal gyrus, adult, donor10258	10368-105F8	144.87	198.24	55.28	21.29	13.98
medial frontal gyrus, newborn, donor10223	10352-105E1	160.79	252.91	61.41	23.03	24.74
medial temporal gyrus - adult, donor10196	10183-103D3	176.34	231.53	79.82	31.22	10.46
medial temporal gyrus, adult, donor10252	10156-103A3	133.91	108.66	49.87	25.89	12.52
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	96.31	231.15	28.89	19.26	21.19
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	803.80	1033.46	272.72	157.89	71.77
medial temporal gyrus, newborn, donor10223	10353-105E2	85.43	190.23	57.07	15.08	36.25
medulla oblongata - adult, donor10196	10174-103C3	157.05	66.84	25.96	13.63	1.95
medulla oblongata, adult, donor10252	10155-103A2	120.44	63.01	32.51	23.84	1.24
medulla oblongata, adult, pool1	10038-101F2	102.52	54.53	30.53	13.88	2.20
medulla oblongata, newborn, donor10223	10361-105F1	93.39	52.77	23.26	8.33	1.74
medulloblastoma cell line:D283 Med	10838-111E1	218.31	52.25	16.83	22.81	0.00
medulloblastoma cell line:ONS-76	10759-110E3	67.25	21.03	11.74	10.03	0.86
melanoma cell line:COLO 679	10514-107E1	78.77	24.58	9.20	8.48	1.29
melanoma cell line:G-361	10465-106H6	90.40	30.68	7.06	10.04	0.54
meningioma cell line:HKBMM	10691-109F7	33.65	5.61	6.69	5.07	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	244.08	33.48	22.91	22.03	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	140.76	23.07	19.96	12.96	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	75.80	17.03	13.04	11.66	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	66.90	17.63	6.91	8.91	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	72.05	14.49	5.80	8.28	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	58.44	15.45	7.45	7.87	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	50.45	16.95	7.32	9.44	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	37.48	22.21	7.63	4.16	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	54.75	11.50	3.78	8.58	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	51.53	11.39	7.82	7.82	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	68.71	14.72	9.28	13.66	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	66.44	21.34	11.21	12.69	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	62.17	16.79	12.95	9.96	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	44.79	10.54	8.23	4.94	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	68.63	15.36	10.79	11.07	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	50.97	12.57	10.82	7.33	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	47.37	14.29	9.19	7.15	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	33.07	14.38	9.35	5.39	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	51.21	16.55	8.90	7.14	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	20.98	9.80	10.94	3.19	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	116.22	39.02	33.15	22.66	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	57.09	14.20	8.52	9.71	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	52.87	12.52	9.45	10.50	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	47.49	13.25	9.20	5.52	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	31.19	10.87	10.30	7.44	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	83.36	24.84	18.10	13.47	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	53.43	12.33	8.68	6.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	75.46	12.02	9.46	7.16	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	62.56	15.97	10.73	5.76	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	52.37	13.56	10.17	6.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	67.78	13.65	7.30	6.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	58.55	13.20	9.14	7.11	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	54.23	14.15	7.47	5.50	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	60.70	14.83	6.95	5.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	79.89	13.56	9.23	8.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	57.78	15.62	7.14	8.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	60.09	13.46	9.13	7.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	60.87	14.67	5.87	5.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	46.99	16.78	6.38	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	52.81	14.74	8.60	4.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.25	12.89	6.87	7.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	43.75	13.67	5.47	5.47	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	5.16	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	52.62	16.56	12.34	3.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	50.92	14.55	10.18	5.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	66.63	18.66	14.39	6.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	48.25	22.90	10.63	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	48.20	14.38	10.11	5.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	92.34	16.79	6.30	8.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	53.65	9.93	9.93	5.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	14.30	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	57.52	17.20	7.71	5.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	60.92	17.06	4.87	4.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	55.10	23.44	14.57	4.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	61.74	19.31	8.97	7.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	58.03	19.34	6.45	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	11.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	6.89	6.89	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	44.82	11.82	4.07	4.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	51.64	7.94	6.36	5.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	44.80	12.38	5.90	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	44.26	11.53	4.05	3.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	54.80	17.38	6.68	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	49.67	17.74	9.46	5.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	12.84	10.27	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	47.50	15.14	4.13	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	59.38	14.35	6.43	4.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	48.22	11.22	8.97	4.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	46.43	13.36	6.36	7.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	31.84	9.67	6.04	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	32.71	10.90	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	3.80	3.80	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	36.41	9.71	6.68	3.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	39.54	8.24	4.12	4.94	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	85.52	18.85	12.10	5.95	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	48.35	12.33	5.84	7.14	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	43.80	10.19	8.15	7.13	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	50.29	11.61	11.61	9.28	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	77.72	16.54	16.06	8.27	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	98.69	31.74	20.39	18.30	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	25.64	0.00	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	77.88	26.20	11.82	12.33	0.00
mesothelioma cell line:Mero-25	10850-111F4	45.39	9.99	6.81	5.67	0.45
mesothelioma cell line:Mero-41	10851-111F5	84.10	13.45	12.96	7.82	0.00
mesothelioma cell line:Mero-48a	10852-111F6	81.71	25.02	17.71	9.08	0.00
mesothelioma cell line:Mero-82	10853-111F7	86.99	27.33	9.99	12.35	0.00
mesothelioma cell line:Mero-83	10854-111F8	70.81	37.11	12.43	10.04	0.17
mesothelioma cell line:Mero-84	10855-111F9	38.67	5.81	11.63	10.62	0.00
mesothelioma cell line:Mero-95	10856-111G1	53.00	27.12	13.04	7.87	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	83.82	22.86	18.88	11.93	0.17
mesothelioma cell line:NCI-H226	10846-111E9	58.10	18.46	18.28	10.86	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	89.17	15.54	17.42	10.42	0.00
mesothelioma cell line:NCI-H28	10845-111E8	117.56	36.39	21.88	11.96	0.76
mesothelioma cell line:No36	10857-111G2	59.37	14.68	11.42	7.83	0.00
mesothelioma cell line:ONE58	10858-111G3	48.77	12.19	11.92	5.96	0.00
migratory langerhans cells, donor1	11901-125F2	109.59	27.64	17.08	9.02	0.00
migratory langerhans cells, donor2	11902-125F3	73.51	11.23	8.06	7.82	0.00
migratory langerhans cells, donor3	11903-125F4	113.97	24.77	12.92	7.90	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	68.56	15.67	13.39	11.10	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	51.29	23.31	16.11	13.14	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	46.99	15.66	6.22	5.76	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	77.45	20.55	13.13	11.04	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	233.21	43.61	21.07	23.47	0.00
myeloma cell line:PCM6	10474-106I6	95.67	64.83	10.08	12.45	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	43.12	16.23	9.64	5.58	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	85.12	19.42	7.65	9.61	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	52.04	9.14	8.69	7.91	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	53.02	9.93	7.50	5.96	0.00
nasal epithelial cells, donor2	12227-129F4	83.35	16.56	13.25	8.83	0.00
neuroblastoma cell line:CHP-134	10508-107D4	310.12	88.57	33.36	29.91	0.23
neuroblastoma cell line:NB-1	10539-107G8	291.85	90.55	63.61	36.86	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	92.79	18.98	8.01	12.02	0.21
neuroblastoma cell line:NH-12	10555-107I6	305.43	51.62	23.85	36.71	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	128.81	26.33	22.54	17.55	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	166.14	24.39	22.97	29.14	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	91.57	26.77	16.30	18.31	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.14	15.89	19.07	8.26	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	66.81	21.03	11.98	7.19	0.00
neutrophil PMN, donor1	12133-128D9	74.37	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	132.81	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	542.88	49.38	83.21	53.10	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	130.48	24.02	18.41	15.21	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	89.13	17.63	12.82	14.43	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	44.14	14.19	12.88	5.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	151.76	178.29	67.30	28.12	11.81
occipital cortex - adult, donor10196	10172-103C1	218.40	267.85	59.75	41.21	12.36
occipital cortex, adult, donor10252	10163-103B1	151.63	101.17	45.62	25.49	17.98
occipital cortex, newborn, donor10223	10355-105E4	76.43	197.26	57.87	14.56	46.22
occipital lobe, adult, donor1	10076-102A4	151.40	146.68	51.43	32.01	14.69
occipital lobe, fetal, donor1	10073-102A1	374.60	227.42	114.57	80.24	2.57
occipital pole, adult, pool1	10036-101E9	110.46	83.89	41.31	15.61	8.91
olfactory region, adult	10195-103E6	136.60	140.61	42.03	20.63	5.54
optic nerve, donor1	10277-104E7	110.06	46.02	28.01	14.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	82.70	15.15	14.69	13.90	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	111.15	15.25	16.76	15.66	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	64.85	18.12	7.28	6.60	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	110.31	18.94	10.16	14.44	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	44.68	11.76	9.11	5.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	83.16	19.62	5.61	6.54	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	108.15	25.87	20.15	19.30	0.00
ovary, adult, pool1	10020-101D2	195.75	18.17	26.99	24.37	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	35.01	15.40	13.20	10.08	0.00
pancreas, adult, donor1	10049-101G4	81.84	17.87	4.70	8.47	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	88.61	21.24	12.02	11.18	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	94.55	16.01	10.22	9.54	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	90.57	9.11	14.57	10.76	0.00
paracentral gyrus, adult, pool1	10035-101E8	142.41	144.70	58.30	24.53	11.17
parietal cortex, adult, donor10258	10373-105G4	171.76	219.47	37.43	4.40	12.48
parietal lobe - adult, donor10196	10171-103B9	163.64	208.79	73.36	27.27	12.23
parietal lobe, adult, donor10252	10157-103A4	137.67	116.01	51.31	27.65	12.83
parietal lobe, adult, pool1	10034-101E7	136.06	126.28	56.31	23.97	11.01
parietal lobe, fetal, donor1	10072-101I9	500.43	225.00	128.99	84.38	1.94
parietal lobe, newborn, donor10223	10356-105E5	85.24	197.77	56.45	20.94	53.46
parotid gland, adult	10199-103F1	84.48	15.42	9.25	3.70	0.00
penis, adult	10200-103F2	118.70	15.04	11.82	8.06	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	130.53	17.85	17.48	13.02	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	82.61	23.60	11.36	13.99	0.29
pineal gland - adult, donor10196	10179-103C8	145.13	135.46	29.67	16.13	0.00
pineal gland, adult, donor10252	10160-103A7	414.55	219.71	49.75	50.34	0.00
pineal gland, adult, donor10258	10377-105G8	154.89	145.48	29.47	14.42	0.00
pituitary gland - adult, donor10196	10180-103C9	192.24	58.68	31.37	26.31	1.01
pituitary gland, adult, donor10252	10162-103A9	492.51	90.16	58.37	51.60	0.52
pituitary gland, adult, donor10258	10378-105G9	234.09	64.69	35.75	19.58	1.70
placenta, adult, pool1	10021-101D3	121.59	19.24	17.74	13.87	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	121.17	23.70	16.82	15.89	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	118.44	17.74	13.23	13.07	0.31
pons, adult, pool1	10033-101E6	156.04	133.40	50.26	26.16	6.11
postcentral gyrus, adult, pool1	10032-101E5	102.87	90.92	42.37	19.79	11.25
promyelocytes/myelocytes PMC, donor1	12132-128D8	66.92	25.10	35.55	16.73	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	27.54	11.02	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	11.74	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	118.86	32.77	20.25	18.35	1.02
prostate cancer cell line:PC-3	10439-106E7	141.21	26.14	25.05	17.97	0.18
prostate, adult, pool1	10022-101D4	157.53	27.30	21.13	16.51	0.09
putamen, adult, donor10196	10176-103C5	159.11	277.37	93.01	36.35	4.25
putamen, adult, donor10252	10152-102I8	170.58	137.25	58.82	33.33	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	138.79	203.26	18.58	18.58	7.65
putamen, adult, donor10258, tech_rep2	10372-105G3	94.71	216.97	32.86	14.26	11.84
putamen, newborn, donor10223	10365-105F5	146.18	191.16	29.24	19.49	28.49
rectal cancer cell line:TT1TKB	10469-106I1	68.66	14.84	13.67	10.18	0.00
rectum, fetal, donor1	10067-101I4	162.75	27.82	38.95	33.38	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	69.11	15.26	17.60	8.06	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	59.65	25.27	27.75	7.46	0.00
retina, adult, pool1	10030-101E3	138.66	31.61	21.77	17.89	0.20
retinoblastoma cell line:Y79	10475-106I7	301.37	72.23	52.48	30.40	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	94.06	34.79	26.68	18.69	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	179.69	35.15	21.65	24.75	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	25.01	12.13	9.09	4.55	0.00
salivary acinar cells, donor1	11771-123I7	61.18	21.20	5.34	6.47	0.00
salivary acinar cells, donor2	11772-123I8	72.56	24.92	7.16	7.99	0.00
salivary acinar cells, donor3	11773-123I9	21.19	8.61	7.28	1.99	0.00
salivary gland, adult, pool1	10093-102C3	135.55	13.73	10.30	9.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	87.68	31.53	10.96	5.31	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	96.16	28.57	11.52	9.40	0.00
seminal vesicle, adult	10201-103F3	92.59	25.40	12.17	7.41	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	89.64	24.78	21.13	14.58	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	53.60	11.07	12.08	5.54	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	69.24	22.08	14.05	6.02	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	95.77	17.60	30.09	16.66	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	78.59	10.17	10.61	9.28	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	105.67	23.35	13.42	12.64	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	61.00	7.80	4.97	8.51	0.00
skeletal muscle, adult, pool1	10023-101D5	146.20	9.12	11.15	12.23	0.00
skeletal muscle, fetal, donor1	10066-101I3	98.49	9.05	13.07	21.11	1.01
skin, adult, donor1	10074-102A2	81.42	0.00	6.79	20.36	0.00
skin, fetal, donor1	10065-101I2	160.96	35.35	10.10	18.31	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	152.09	24.68	15.01	22.35	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	121.67	39.72	24.27	18.60	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	197.18	44.33	24.86	30.45	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	305.42	56.87	27.36	31.32	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	174.36	18.82	37.80	33.14	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	142.08	40.31	18.74	21.14	0.00
small intestine, adult, pool1	10024-101D6	147.99	19.83	15.65	13.14	0.00
small intestine, fetal, donor1	10064-101I1	128.25	23.59	20.88	25.06	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	63.60	14.87	8.21	8.21	0.00
smooth muscle, adult, pool1	10048-101G3	147.06	14.99	16.54	19.64	0.00
somatostatinoma cell line:QGP-1	10781-110G7	77.19	21.71	12.60	9.11	0.00
spinal cord - adult, donor10196	10181-103D1	128.01	68.13	42.21	19.96	1.38
spinal cord, adult, donor10252	10159-103A6	183.73	91.47	37.06	28.78	0.00
spinal cord, adult, donor10258	10369-105F9	200.62	115.53	22.14	15.22	3.46
spinal cord, fetal, donor1	10056-101H2	135.38	60.98	25.00	21.95	3.05
spinal cord, newborn, donor10223	10359-105E8	123.53	50.97	29.39	16.53	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	41.97	10.60	8.66	5.53	0.00
spleen, adult, pool1	10025-101D7	128.09	21.81	14.76	13.33	0.11
spleen, fetal, pool1	10044-101F8	97.81	17.48	21.29	13.51	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	110.24	37.26	25.15	14.39	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	72.91	20.13	13.67	10.25	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	82.12	26.21	10.48	10.83	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	46.91	23.46	6.25	9.38	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	145.76	52.56	28.82	21.95	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	133.86	53.80	24.57	10.17	5.08
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	74.88	12.69	8.46	5.08	1.69
stomach, fetal, donor1	10062-101H8	75.83	9.61	20.29	10.68	0.00
submaxillary gland, adult	10202-103F4	87.16	15.95	9.11	6.27	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	217.10	162.82	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	122.96	72.90	36.97	29.49	0.21
substantia nigra, adult, donor10258	10371-105G2	166.04	120.00	22.76	11.38	8.28
substantia nigra, newborn, donor10223	10358-105E7	83.38	50.87	21.90	10.60	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	174.93	68.78	42.64	30.49	0.23
temporal lobe, adult, pool1	10031-101E4	96.89	98.08	41.37	18.73	10.60
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	267.10	151.00	61.97	42.02	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	163.95	141.09	50.55	19.34	1.32
tenocyte, donor1	11763-123H8	58.65	17.46	8.38	5.93	0.00
tenocyte, donor2	11765-123I1	56.08	16.79	7.63	5.34	0.00
tenocyte, donor3	11768-123I4	53.01	18.53	8.90	5.56	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	191.72	50.48	42.32	30.08	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	162.47	23.74	19.89	25.59	0.00
teratocarcinoma cell line:PA-1	10807-111A6	155.29	48.97	24.02	22.47	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	80.99	32.24	19.68	19.93	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	103.62	52.94	21.56	17.02	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	117.79	53.11	28.25	25.30	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	114.65	27.36	16.94	16.94	0.00
testis, adult, pool1	10026-101D8	168.36	39.62	50.89	32.53	0.21
testis, adult, pool2	10096-102C6	117.28	34.28	34.73	14.89	0.45
thalamus - adult, donor10196	10168-103B6	182.16	132.48	51.89	24.29	1.10
thalamus, adult, donor10252	10154-103A1	135.34	74.39	38.91	28.60	2.19
thalamus, adult, donor10258, tech_rep1	10370-105G1	118.55	192.45	16.94	9.24	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	78.56	63.08	30.30	14.00	7.08
thalamus, newborn, donor10223	10366-105F6	55.81	122.54	26.46	12.08	17.83
throat, adult	10209-103G2	101.37	14.73	9.49	6.74	0.00
throat, fetal, donor1	10061-101H7	172.16	34.13	25.90	26.51	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	162.17	53.86	22.85	17.09	0.00
thymus, adult, pool1	10027-101D9	277.77	49.51	34.40	30.62	0.00
thymus, fetal, pool1	10043-101F7	241.27	35.95	35.64	29.92	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	79.38	20.74	15.96	8.51	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	116.92	25.70	16.76	17.46	0.42
thyroid, adult, pool1	10028-101E1	221.90	44.04	32.10	22.21	0.00
thyroid, fetal, donor1	10060-101H6	136.31	46.40	29.27	25.31	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	24.64	9.24	9.24	0.00
tongue, adult	10203-103F5	88.38	11.86	10.23	9.77	0.00
tongue, fetal, donor1	10059-101H5	150.54	13.79	18.92	18.52	0.00
tonsil, adult, pool1	10047-101G2	109.59	17.53	14.93	13.72	0.20
trachea, adult, pool1	10029-101E2	120.16	18.90	15.71	11.29	0.00
trachea, fetal, donor1	10058-101H4	154.26	19.62	19.23	21.16	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	47.83	8.86	8.50	9.21	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	153.19	45.19	22.39	16.21	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	178.31	46.22	20.84	16.14	0.00
tridermal teratoma cell line:HGRT	10694-109G1	28.54	7.61	5.71	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	100.82	13.12	14.64	13.80	0.25
umbilical cord, fetal, donor1	10057-101H3	75.11	2.09	8.35	6.26	0.00
uterus, adult, pool1	10100-102D1	244.85	28.84	34.98	25.08	0.17
uterus, fetal, donor1	10055-101H1	152.55	30.72	30.72	22.01	0.00
vagina, adult	10204-103F6	99.51	16.15	14.22	14.22	0.00
vein, adult	10191-103E2	80.23	15.12	11.40	7.67	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	64.62	16.82	11.48	10.41	0.00